Platelet size has been demonstrated to reflect platelet activity and seems to be a useful
predictive and prognostic biomarker of cardiovascular events. It is associated with a variety …

Haemostasis and thrombosis are complex, multifactorial processes. There is an evolving
understanding of the mechanisms influencing vascular occlusion and the role of …

Background Critically ill patients diagnosed with COVID-19 may develop a pro-thrombotic
state that places them at a dramatically increased lethal risk. Although platelet activation is …

Objective Heightened inflammation, dysregulated immunity, and thrombotic events are
characteristic of hospitalized COVID‐19 patients. Given that platelets are key regulators of …

Most loci identified by GWASs have been found in populations of European ancestry (EUR).
In trans-ethnic meta-analyses for 15 hematological traits in 746,667 participants, including …

Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date …

Circulating blood platelets are specialized cells that prevent bleeding and minimize blood
vessel injury. Large progenitor cells in the bone marrow called megakaryocytes (MKs) are …

Sažetak Platelet indices (PI)—plateletcrit, mean platelet volume (MPV) and platelet
distribution width (PDW)—are a group of derived platelet parameters obtained as a part of …

Platelet activation is a link in the pathophysiology of diseases prone to thrombosis and
inflammation. Numerous platelet markers, including mean platelet volume (MPV), have been …

Several hundreds of studies recently investigated mean platelet volume (MPV) as measured
by electronic cell counters in a wide variety of acquired diseases, and most of them found …